Synovus Financial Corp Fibrogen Inc Transaction History

Synovus Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 09, 2020	SELL	$40.47 - $45.5 $3,278 - $3,685	-81 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$32.57 - $42.83 $6,514 - $8,566	-200 Reduced 71.17%	81 $3,000
Q1 2020 Apr 24, 2020	BUY	$23.3 - $45.96 $4,660 - $9,192	200 Added 246.91%	281 $10,000
Q3 2018 Nov 01, 2018	BUY	$56.3 - $67.25 $4,560 - $5,447	81 New	81 $5,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Synovus Financial Corp with notifications on news.